ATOM vs DXCM · rev $135.0K vs P/E 63, rev $4.03B
Atomera Inc (ATOM) versus DexCom Inc (DXCM) — a side-by-side from cached financials, not a winner call.
Atomera Inc (ATOM) is a semiconductor equipment & materials company listed on US.
DexCom Inc (DXCM) is a medical devices company listed on US.
Latest reported ATOM revenue for 2024-12-31 was $135.0K. Net income was -$18.4M. Revenue was down 75.5% from 2023-12-31 to 2024-12-31. ATOM currently screens at market cap $341.1M.
Latest reported DXCM revenue for 2024-12-31 was $4.03B. Net income was $576.2M. Revenue was up 11.3% from 2023-12-31 to 2024-12-31. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
ATOM currently screens at market cap $341.1M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Not investment advice. Open the ATOM and DXCM stock pages for the full models.
Not investment advice.